Homo sapiens kinase insert domain receptor (a type III receptor tyrosine kinase) (KDR)
Synonyms:
CD309; FLK1; VEGFR; VEGFR2
Immunogen
The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 1175 (K-D-YP-I-V).
Buffer
phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Clone Name
Isotype
Species Reactivity
Human, Mouse, Rat
Concentration
1ug/ul
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific phosphopeptide. The antibody against non-phosphopeptide was removedby chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site. (Protein A or G Sepharose)
Guaranteed Application *
IHC
Suggested Dilutions
IHC: 1:50~1:100
Background
Related Pathway
Cytokine-cytokine receptor interaction
Focal Adhesion
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
